CAS: 25129-20-8; (2R,2'R)-3,3'-Disulfanediylbis(2-Benzamidopropanoic Acid)

该化合物是一种化学化合物,其结构特征包括两个与细胞分子相连的苯并基组,Cystine本身是细胞的二极分,通过两种细胞残渣氧化形成,导致脱硫结合.该化合物因其在蛋白结构和功能中的作用,通常用于生物化学和药物应用.N,N欧元-二苯-L-细胞展示其特性,如有机溶剂溶液和水溶液有限,这在大芳香组化合物中很常见.它可以参与各种化学反应,包括涉及硫醇组的化学反应,使其与红氧化生物学和蛋白折叠研究有关.苯并会增强其稳定性和影响其反应力.与许多化学物质一样,在处理N,N-二苯基-西丁时,应注意安全防范措施,因为如果是吸入或吸入,则可能对健康造成风险.

结构式图片

相似化合物

6968-11-2 32513-92-1 2566-22-5

上下游产品

dimethyl 3,3'-disulfanediyl(2R,2'R)-bis(2-benzamidopropanoate) N,N'-dibenzoyl-DL-cystineN,N'-dibenzoyl-DL-cystine L-cystine benzoyl chloridedimethyl 3,3'-disulfanediyl(2R,2'R)-bis(2-benzamidopropanoate) 2-benzamido-3-mercaptopropanoic acid N-benzoyl-L-alanine DL-N-benzoylcysteine

合成工艺路线路线简述

    📜N,N'-Dibenzoyl-L-Cystine Dimethyl Ester置于盐酸体系中,化学反应生成L-胱氨酸
    参考文献:Voss; Guttmann; Klemm,Biochemische Zeitschrift,1930,Vol. 220,P. 327,340
    标题:Voss; Guttmann; Klemm,Biochemische Zeitschrift,1930,Vol. 220,P. 327,340

    海关参考信息

    专利信息


    专利号:US-7935827-B2
    优先权日:2003-12-31
    标题 :Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters
    发明人:PLATZEK JOHANNES; ZORN LUDWIG; BUCHMANN BERND; SKUBALLA WERNER; PETROV ORLIN
    权利人:BAYER SCHERING PHARMA AG
    摘要:The present invention relates to new optically active heteroaromatic β-hydroxy esters useful in the synthesis of epothilone derivatives, to certain compounds used to produce these intermediates, as well as to processes for their production.

    专利号:US-2005267056-A1
    优先权日:2003-09-15
    标 题:Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives

    专利号:EP-1670809-B1
    优先权日:2003-09-15
    标 题:Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
    发明人:PHIASIVONGSA PASIT; REDKAR SANJEEV
    权利人:MAYNE PHARMA PLC

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/j.jconrel.2004.03.012
    摘要:Friggeri A, Feringa BL, van Esch J. Entrapment and release of quinoline derivatives using a hydrogel of a low molecular weight gelator. J Control Release. 2004 Jun 18;97(2):241–8. doi: 10.1016/j.jconrel.2004.03.012.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知